• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inflammatory bowel disease unclassified.未分类的炎症性肠病。
J Zhejiang Univ Sci B. 2011 Apr;12(4):280-6. doi: 10.1631/jzus.B1000172.
2
Treatment Options and Outcomes of Pediatric IBDU Compared with Other IBD Subtypes: A Retrospective Multicenter Study from the IBD Porto Group of ESPGHAN.与其他炎症性肠病亚型相比,儿童未定型炎症性肠病的治疗选择和结局:欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)IBD波尔图组的一项回顾性多中心研究
Inflamm Bowel Dis. 2016 Jun;22(6):1378-83. doi: 10.1097/MIB.0000000000000767.
3
Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.欧洲基于人群的发病队列中未分类炎症性肠病的疾病进程:一项 Epi-IBD 研究。
J Gastroenterol Hepatol. 2019 Jun;34(6):996-1003. doi: 10.1111/jgh.14563. Epub 2019 Jan 21.
4
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.儿童及青年溃疡性结肠炎与克罗恩病的鉴别:北美儿科胃肠病学、肝病学和营养学会及美国克罗恩病和结肠炎基金会工作组报告
J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3.
5
Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).胶囊内镜在溃疡性结肠炎和未分类型炎症性肠病(IBDU)中的诊断率。
Endoscopy. 2008 Jan;40(1):30-5. doi: 10.1055/s-2007-995359. Epub 2007 Dec 5.
6
Clinical features of inflammatory bowel disease unclassified: a case-control study.未分类炎症性肠病的临床特征:一项病例对照研究。
BMC Gastroenterol. 2024 Mar 13;24(1):105. doi: 10.1186/s12876-024-03171-5.
7
Inflammatory Bowel Disease-Unclassified in Children: Diagnosis and Pharmacological Management.儿童未分类的炎症性肠病:诊断与药物治疗
Paediatr Drugs. 2017 Apr;19(2):113-120. doi: 10.1007/s40272-017-0213-9.
8
East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.欧洲炎症性肠病发病率的东西梯度:ECCO-EpiCom 起始队列。
Gut. 2014 Apr;63(4):588-97. doi: 10.1136/gutjnl-2013-304636. Epub 2013 Apr 20.
9
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified).无线胶囊内镜在不明原因结肠炎(未分类炎症性肠病类型)患者中的价值。
Inflamm Bowel Dis. 2007 Feb;13(2):152-5. doi: 10.1002/ibd.20060.
10
Short noncoding RNAs as predictive biomarkers for the development from inflammatory bowel disease unclassified to Crohn's disease or ulcerative colitis.短非编码 RNA 作为从未分类炎症性肠病发展为克罗恩病或溃疡性结肠炎的预测生物标志物。
PLoS One. 2024 Feb 26;19(2):e0297353. doi: 10.1371/journal.pone.0297353. eCollection 2024.

引用本文的文献

1
Prebiotic selection influencing inflammatory bowel disease treatment outcomes: a review of the preclinical and clinical evidence.影响炎症性肠病治疗结果的益生元选择:临床前和临床证据综述
eGastroenterology. 2024 Apr 3;2(2):e100055. doi: 10.1136/egastro-2023-100055. eCollection 2024 Apr.
2
Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy.小肠胶囊内镜未分类的炎症性肠病的再分类。
Medicina (Kaunas). 2023 Nov 23;59(12):2064. doi: 10.3390/medicina59122064.
3
Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease.乌司奴单抗治疗炎症性肠病的真实世界持久性。
Adv Ther. 2023 Oct;40(10):4421-4439. doi: 10.1007/s12325-023-02611-0. Epub 2023 Jul 28.
4
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.西班牙炎症性肠病(溃疡性结肠炎和克罗恩病)的流行病学、临床、患者报告和经济负担:系统评价。
Adv Ther. 2023 May;40(5):1975-2014. doi: 10.1007/s12325-023-02473-6. Epub 2023 Mar 16.
5
Racial or ethnic differences on treatment adherence and persistence among patients with inflammatory bowel diseases initiated with biologic therapies.生物治疗起始的炎症性肠病患者在治疗依从性和持久性方面的种族或民族差异。
BMC Gastroenterol. 2022 Dec 29;22(1):545. doi: 10.1186/s12876-022-02560-y.
6
The role of small-bowel endoscopy in inflammatory bowel disease: an updated review on the state-of-the-art in 2021.小肠内镜检查在炎症性肠病中的作用:2021年最新技术综述
Ann Gastroenterol. 2021 Sep-Oct;34(5):599-611. doi: 10.20524/aog.2021.0652. Epub 2021 Jul 2.
7
Developing an Online Program for Self-Management of Fatigue, Pain, and Urgency in Inflammatory Bowel Disease: Patients' Needs and Wants.开发炎症性肠病疲劳、疼痛和紧迫感的在线自我管理计划:患者的需求。
Dig Dis Sci. 2022 Jul;67(7):2813-2826. doi: 10.1007/s10620-021-07109-9. Epub 2021 Jun 19.
8
Perinatal risk factors for pediatric onset type 1 diabetes, autoimmune thyroiditis, juvenile idiopathic arthritis, and inflammatory bowel diseases.围产期致儿科起病 1 型糖尿病、自身免疫性甲状腺炎、幼年特发性关节炎和炎症性肠病的风险因素。
Eur J Pediatr. 2021 Jul;180(7):2115-2123. doi: 10.1007/s00431-021-03987-3. Epub 2021 Feb 23.
9
An Overview of Inflammatory Bowel Disease Unclassified in Children.儿童未分类炎症性肠病概述
Inflamm Intest Dis. 2019 Aug;4(3):97-103. doi: 10.1159/000501519. Epub 2019 Jul 19.
10
Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder Presenting as Chronic Diarrhea and Intestinal Bleeding: A Case Report. Epstein-Barr 病毒相关性 T 细胞淋巴组织增生性疾病以慢性腹泻和肠出血为表现:病例报告。
Front Immunol. 2018 Nov 16;9:2583. doi: 10.3389/fimmu.2018.02583. eCollection 2018.

本文引用的文献

1
New serologic markers for inflammatory bowel disease diagnosis.炎症性肠病诊断的新型血清学标志物。
Dig Dis. 2010;28(3):418-23. doi: 10.1159/000320396. Epub 2010 Sep 30.
2
Tumor necrosis factor blockade for treatment of inflammatory bowel disease: efficacy and safety.肿瘤坏死因子阻断剂治疗炎症性肠病:疗效和安全性。
Curr Mol Pharmacol. 2010 Nov;3(3):145-52. doi: 10.2174/1874467211003030145.
3
Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit.炎症性肠病中的潜在可避免手术:有多少患者在术前未接受最佳治疗的情况下接受了切除术?一项基于指南的审核。
Intern Med J. 2012 May;42(5):e84-8. doi: 10.1111/j.1445-5994.2010.02328.x. Epub 2010 Jul 30.
4
Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.血清学标志物:对炎症性肠病的早期诊断和疾病分层的影响。
Postgrad Med. 2010 Jul;122(4):177-85. doi: 10.3810/pgm.2010.07.2184.
5
Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients.硫唑嘌呤对依赖皮质类固醇的亚洲炎症性肠病患者有效。
Inflamm Bowel Dis. 2011 Mar;17(3):809-15. doi: 10.1002/ibd.21382.
6
Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease.慢性活动性炎症性肠病患者行粒细胞和单核细胞单采术再治疗的长期随访。
BMC Gastroenterol. 2010 Jul 6;10:73. doi: 10.1186/1471-230X-10-73.
7
Serologic and laboratory markers in prediction of the disease course in inflammatory bowel disease.炎症性肠病病程预测的血清学和实验室标志物。
World J Gastroenterol. 2010 Jun 7;16(21):2604-8. doi: 10.3748/wjg.v16.i21.2604.
8
The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients.硫嘌呤治疗对炎症性肠病患者健康相关生活质量的影响。
BMC Gastroenterol. 2010 Mar 2;10:26. doi: 10.1186/1471-230X-10-26.
9
Clinical outcomes of ileorectal anastomosis for ulcerative colitis.溃疡性结肠炎回直肠吻合术的临床结局
Br J Surg. 2010 Jan;97(1):65-9. doi: 10.1002/bjs.6809.
10
Diagnostic advances in inflammatory bowel disease (imaging and laboratory).炎症性肠病的诊断进展(影像学与实验室检查)
Curr Gastroenterol Rep. 2009 Dec;11(6):488-95. doi: 10.1007/s11894-009-0074-7.

未分类的炎症性肠病。

Inflammatory bowel disease unclassified.

机构信息

Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

出版信息

J Zhejiang Univ Sci B. 2011 Apr;12(4):280-6. doi: 10.1631/jzus.B1000172.

DOI:10.1631/jzus.B1000172
PMID:21462383
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3072591/
Abstract

OBJECTIVE

Inflammatory bowel diseases (IBDs) are idiopathic, chronic, and inflammatory intestinal disorders. The two main types, ulcerative colitis (UC) and Crohn's disease (CD), sometimes mimic each other and are not readily distinguishable. The purpose of this study was to present a series of hospitalized cases, which could not initially be classified as a subtype of IBD, and to try to note roles of the terms indeterminate colitis (IC) and inflammatory bowel disease unclassified (IBDU) when such a dilemma arises.

METHODS

Medical records of 477 patients hospitalized due to IBD, during the period of January 2002 to April 2009, were retrospectively studied in the present paper. All available previous biopsies from endoscopies of these patients were reanalyzed.

RESULTS

Twenty-seven of 477 IBD patients (5.7%) had been initially diagnosed as having IBDU. Of them, 23 received colonoscopy and histological examinations in our hospital. A total of 90% (9/10) and 66.7% (4/6) of patients, respectively, had a positive finding via wireless capsule endoscopy (CE) and double-balloon enteroscopy (DBE). The barium-swallow or small bowel follow-through (SBFT) was performed on 11 patients. Positive changes were observed under computer tomographic (CT) scanning in 89.5% (17/19) of patients. Reasonable treatment strategies were employed for all patients.

CONCLUSIONS

Our data indicate that IBDU accounts for 5.7% of initial diagnoses of IBD. The definition of IBDU is valuable in clinical practice. For those who had no clear clinical, endoscopic, histological, or other features affording a diagnosis of either UC or CD, IBDU could be used parenthetically.

摘要

目的

炎症性肠病(IBD)是一种特发性、慢性和炎症性肠病。两种主要类型,溃疡性结肠炎(UC)和克罗恩病(CD),有时相互模仿,不易区分。本研究的目的是介绍一系列最初不能分类为 IBD 亚型的住院病例,并试图在出现这种困境时注意到不确定结肠炎(IC)和未分类炎症性肠病(IBDU)的作用。

方法

回顾性研究了 2002 年 1 月至 2009 年 4 月期间因 IBD 住院的 477 例患者的病历。重新分析了这些患者内镜检查的所有先前活检。

结果

477 例 IBD 患者中有 27 例(5.7%)最初被诊断为 IBDU。其中,23 例在我院接受了结肠镜和组织学检查。90%(9/10)和 66.7%(4/6)的患者分别通过无线胶囊内镜(CE)和双气囊内镜(DBE)获得阳性发现。11 例患者进行了钡剂吞咽或小肠随诊(SBFT)。89.5%(17/19)的患者在计算机断层扫描(CT)扫描下观察到阳性变化。所有患者均采用合理的治疗策略。

结论

我们的数据表明,IBDU 占 IBD 初始诊断的 5.7%。IBDU 的定义在临床实践中是有价值的。对于那些没有明确的临床、内镜、组织学或其他特征可诊断为 UC 或 CD 的患者,可以使用 IBDU 进行括号内诊断。